Literature DB >> 10793215

Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression.

S C Benoit1, T E Thiele, S C Heinrichs, P A Rushing, K A Blake, R J Steeley.   

Abstract

Corticotropin-releasing hormone (CRH) is a potent regulator of the hypothalamic-pituitary-adrenal axis, and reduces food intake when administered into the third cerebral ventricle (i3vt). However, CRH also promotes conditioned taste aversion (CTA) learning which indicates that its anorectic effects are accompanied by aversive consequences that would reduce food intake independently of energy regulation. Urocortin (Ucn) is a closely related mammalian peptide that binds to both identified CRH receptor subtypes and also reduces food intake when administered i3vt. The present experiments compared the aversive consequences of i3vt administration of CRH and Ucn at doses that produced comparable decrements in food intake. Experiment 1 found that 1.0 microg Ucn and 2.0 microg CRH produced similar reductions in food intake. Experiment 2 demonstrated that, at these doses, CRH but not Ucn promoted robust and reliable CTA learning. A third experiment showed comparable increased c-Fos-like immunoreactivity after Ucn and CRH in forebrain and hindbrain structures associated with food intake. It is concluded that Ucn, at doses that reduce food intake to levels like that observed after administration of CRH, do not produce similarly aversive consequences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10793215     DOI: 10.1016/s0196-9781(00)00153-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  15 in total

1.  Distribution of corticotropin-releasing factor and urocortin 1 in the vole brain.

Authors:  Miranda M Lim; Natalia O Tsivkovskaia; Yaohui Bai; Larry J Young; Andrey E Ryabinin
Journal:  Brain Behav Evol       Date:  2006-06-30       Impact factor: 1.808

2.  The role of central CB2 cannabinoid receptors on food intake in neonatal chicks.

Authors:  L Emadi; H Jonaidi; E Hosseini Amir Abad
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2011-09-07       Impact factor: 1.836

Review 3.  Melanocortin control of energy balance: evidence from rodent models.

Authors:  Bart C De Jonghe; Matthew R Hayes; Kendra K Bence
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

4.  Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.

Authors:  Koji Yakabi; Masamichi Noguchi; Shino Ohno; Shoki Ro; Tsuneko Onouchi; Mitsuko Ochiai; Hidehiko Takabayashi; Kiyoshige Takayama; Yumi Harada; Chiharu Sadakane; Tomohisa Hattori
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-03       Impact factor: 4.310

5.  Palatable food avoidance and acceptance learning with different stressors in female rats.

Authors:  N-C Liang; M E Smith; T H Moran
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

Review 6.  Hypothalamic-brainstem circuits controlling eating.

Authors:  James E Blevins; Denis G Baskin
Journal:  Forum Nutr       Date:  2009-11-27

Review 7.  Urocortin and the brain.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-11-07       Impact factor: 11.685

8.  The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.

Authors:  A J Lawrence; E V Krstew; F M Dautzenberg; A Rühmann
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  ComparativeStudyofCRHMicroinjections Into PVN and CeA Nuclei on Food Intake, Ghrelin, Leptin, and Glucose Levels in Acute Stressed Rats.

Authors:  Maryam Radahmadi; Mina Sadat Izadi; Atefeh Rayatpour; Maedeh Ghasemi
Journal:  Basic Clin Neurosci       Date:  2021-01-01

Review 10.  CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Neurosci       Date:  2014-03-18       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.